Cargando…

R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T

Effective transverse relaxivity of gadolinium-based contrast agents is often neglected in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Here, we assess time and tissue dependence of R2* enhancement and its impact on pharmacokinetic parameter quantification and treatment monitoring....

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jana, Moestue, Siver A., Bathen, Tone F., Kim, Eugene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Grapho Publications, LLC 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752293/ https://www.ncbi.nlm.nih.gov/pubmed/31572792 http://dx.doi.org/10.18383/j.tom.2019.00015

Ejemplares similares

Intravascular Targets for Molecular Contrast-Enhanced Ultrasound Imaging
por: Moestue, Siver A., et al.
Publicado: (2012)

Identification of Metastasis-Associated Metabolic Profiles of Tumors by (1)H-HR-MAS-MRS()()()
por: Gorad, Saurabh S., et al.
Publicado: (2015)

APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer
por: Søgaard, Caroline K., et al.
Publicado: (2018)

Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies
por: Haukaas, Tonje H., et al.
Publicado: (2016)

Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
por: Itkonen, Harri M., et al.
Publicado: (2016)

Non-Invasive Prostate Cancer Characterization with Diffusion-Weighted MRI: Insight from In silico Studies of a Transgenic Mouse Model
por: Hill, Deborah K., et al.
Publicado: (2017)

Detection of Recurrent Prostate Cancer With (18)F-Fluciclovine PET/MRI
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2020)

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
por: Barkovskaya, Anna, et al.
Publicado: (2019)

Castration-resistant prostate cancer cells are dependent on the high activity of CDK7
por: Pallasaho, Satu, et al.
Publicado: (2022)

Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model
por: Kim, Eugene, et al.
Publicado: (2016)

Influence of B(1)-Inhomogeneity on Pharmacokinetic Modeling of Dynamic Contrast-Enhanced MRI: A Simulation Study
por: Park, Bumwoo, et al.
Publicado: (2017)

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
por: Grinde, Maria T, et al.
Publicado: (2014)

Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics
por: Wang, Hai-yi, et al.
Publicado: (2017)

Influence of Oxidation Degree of Graphene Oxide on Its Nuclear Relaxivity and Contrast in MRI
por: Mohanta, Zinia, et al.
Publicado: (2020)

Design and synthesis of chiral DOTA-based MRI contrast agents with remarkable relaxivities
por: Zhang, Junhui, et al.
Publicado: (2023)

The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data
por: Gill, Andrew B., et al.
Publicado: (2015)

Pulmonary MRI contrast using Surface Quadrupolar Relaxation (SQUARE) of hyperpolarized (83)Kr()
por: Six, Joseph S., et al.
Publicado: (2014)

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer
por: Grinde, Maria T., et al.
Publicado: (2019)

Pharmacokinetic Changes Induced by Focused Ultrasound in Glioma-Bearing Rats as Measured by Dynamic Contrast-Enhanced MRI
por: Yang, Feng-Yi, et al.
Publicado: (2014)

The Principal of Dynamic Contrast Enhanced MRI, the Method of Pharmacokinetic Analysis, and Its Application in the Head and Neck Region
por: Chikui, Toru, et al.
Publicado: (2012)

DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data
por: Ortuño, Juan E, et al.
Publicado: (2013)

Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI
por: Zhao, Weiwei, et al.
Publicado: (2018)

Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI
por: Ulas, Cagdas, et al.
Publicado: (2019)

Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content
por: Kamimura, Kiyohisa, et al.
Publicado: (2021)

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
por: Barkovskaya, Anna, et al.
Publicado: (2020)

Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells
por: Tunset, Hanna Maja, et al.
Publicado: (2019)

Longitudinal and Transverse Relaxivity Analysis of Native Ferritin and Magnetoferritin at 7 T MRI
por: Strbak, Oliver, et al.
Publicado: (2021)

Enhanced MRI T(2) Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles
por: Thapa, Bibek, et al.
Publicado: (2017)

Polymerizable Gd(iii) building blocks for the synthesis of high relaxivity macromolecular MRI contrast agents
por: Berki, Thomas R., et al.
Publicado: (2021)

Correlation analysis between the complex electrical permittivity and relaxation time of tissue mimicking phantoms in 7 T MRI
por: Hernandez, Daniel, et al.
Publicado: (2022)

Migraine: An Underestimated Neurological Condition Affecting Billions
por: Gupta, Jatin, et al.
Publicado: (2022)

Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2α Activatable Fluorophore
por: Chiorazzo, Michael G., et al.
Publicado: (2019)

Correction: Pharmacokinetic Changes Induced by Focused Ultrasound in Glioma-Bearing Rats as Measured by Dynamic Contrast-Enhanced MRI
Publicado: (2014)

Suitability of Pharmacokinetic Models for Dynamic Contrast-Enhanced MRI of Abdominal Aortic Aneurysm Vessel Wall: A Comparison
por: Nguyen, V. Lai, et al.
Publicado: (2013)

Label-set impact on deep learning-based prostate segmentation on MRI
por: Meglič, Jakob, et al.
Publicado: (2023)

Dynamic contrast-enhanced breast MRI at 7T and 3T: an intra-individual comparison study
por: Menezes, Gisela L. G., et al.
Publicado: (2016)

7T dynamic contrast‐enhanced MRI for the detection of subtle blood–brain barrier leakage
por: Canjels, Lisanne P. W., et al.
Publicado: (2021)

Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization
por: Ochoa-Albiztegui, R. Elena, et al.
Publicado: (2020)

Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions
por: Kang, Yeonah, et al.
Publicado: (2020)

Preoperative Measurement of Cartilage Defects by MRI Underestimates Lesion Size
por: Gomoll, Andreas H., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0f3tqcjqn1i8i8ahi1teladnt9